Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy

Clinical Nephrology

Volumn 59, Issue 2, 2003, Pages 124-129

  Weisshaar, E ^a   Dunker, N ^a   Domrose U ^a   Neumann, K H ^a   Gollnick, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

5 hydroxytryptamine; Antihistamine; Antiserotonergic; Cetirizine; Hemodialysis; Histamine; Itch; Ondansetron; Pruritus; Serotonin; Tropisetron

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CORTICOTROPIN; HISTAMINE; ONDANSETRON; PHENOTHIAZINE; SEROTONIN; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEMODIALYSIS PATIENT; HISTAMINE BLOOD LEVEL; HUMAN; MALE; MAST CELL; MEDIATOR; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEROTONIN BLOOD LEVEL;

EID: 0037320111     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP59124     Document Type: Article

References (42)

1. Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystin H 2000 Ondansetron therapy for uremic patients in hemodialysis. Am J Kidney Dis 35: 827-831
2. Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A 1998 Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 78: 395-402
3. Bencini PL, Montagnino G, Citterio A, Graziani G, Crosti C, Ponticelli C 1985 Cutaneous abnormalities in uremic patients. Nephron 40: 316-321
4. Carmichael AJ, McHugh MI, Martin AM 1991 Renal itch as an indicator of poor outcome. Lancet 337: 125-126
5. Carmichael AJ, McHugh MM, Martin AM, Farrow M 1988 Serological markers of renal itch in patients receiving long-term hemodialysis. Br Med J 296: 1575
6. Chaveau J, Fert V, Morel A, Delaage MA 1991 A new and specific immunoassay of serotonin. Clin Chem 37: 1178-1184
7. Cohen EP, Russel TJ, Garancis JC 1992 Mast cells and calcium in severe uremic itching. Am J Med Sci 303: 360-65
8. Dallapiccola B, Tataranni G, Farinelli A 1972 Uraemia and mast cell proliferation. Lancet 1: 1231
9. DeFilippi C, Regazzini R, Piazza V, Galli F, Pisati P, Sacchi S, Salvadeo A 1995 Uremic pruritus is not related to plasma histamine concentrations. Clin Exp Dermatol 20: 294-296
10. De Marchi S, Cecchin E, Villalta D, Sepiacci G, Santini G, Bartoli E 1992 Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 326: 969-974
11. Dimkovic N, Djukanovic L, Radmilovic A, Bojic P, Juloski T 1992 Uremic pruritus and skin mast cells. Nephron 61: 5-9
12. Francos GC, Kauh YC, Gittlen SD, Schulman ES, Basarab A, Goyal S, Burke JF 1991 Elevated plasma histamine in chronic uremia. Int J Dermatol 30: 884-889
13. Gilchrest BA, Stern RS, Steinman TI, Brown R, Arendt K, Anderson W 1982 Clinical features among patients undergoing maintenance hemodialysis. Arch Dermatol 118: 154-156
14. Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P 1991 Plasma histamine in patients with chronic renal failure and nephrotic syndrome. Clin Pathol 44: 243-245
15. Goicoechea M, de Sequera P, Ochando A, Andrea C, Caramelo C 1999 Uremic pruritus: an unresolved problem in hemodialysis patients. Nephron 82: 73-74
16. Graf H, Kovarik J, Stummvoll HK, Wolf A 1979 Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J 279: 1478-1479
17. Gregory RE, Ettinger DS 1998 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs 55: 173-189
18. Hampers CL, Katz AJ, Wilson RE, Merril JP 1968 Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med 279: 695-697
19. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A 1995 Optimal dialysis improves uremic pruritus. Am J Kidney Dis 25: 413-419
20. Kerr PG, Argiles A, Mion C 1992 Whole blood serotonin levels are markedly elevated in patients on dialytic therapy. Am J Nephrol 12: 14-18
21. Klein LR, Klein JB, Hanno R, Callen JP 1988 Cutaneous mast cell quantity in pruritic and non-pruritic hemodialysis patients. Int J Dermatol 27: 557-559
22. McBride P, Bradley D, Kaliner M 1988 Evaluation of a radioimmunoassay for histamine measurement in biological fluids. J Allergy Clin Immunol 82: 638-646
23. Masi CM, Cohen EP 1992 Dialysis efficacy and itching in renal failure. Nephron 62: 257-261
24. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR 1968 Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N Engl J Med 26: 697-700
25. Matsumoto M, Ichimaru K, Horie A 1985 Pruritus and mast cell proliferation of the skin in end-stage renal failure. Clin Nephrol 23: 285-298
26. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT for the Necosad Study Group 1999 Physical symptoms and quality of life in patients on chronic dialysis: results of the Netherland cooperative study on adequacy of dialysis (NECOSAD). Nephrol Dial Transplant 14: 1163-1170
27. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U 1990 Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD): the role of plasma histamine and mast cells. Clin Nephrol 34: 136-141
28. Murphy M, Carmichael AJ 2000 Renal itch. Clin Exp Dermatol 25: 103-106
29. Neimann RS, Bischel MD, Lukes RJ 1972 Uremia and mast cell proliferation. Lancet 1: 959
30. Parbtani A, Frampton G, Cameron JS 1980 Platelet and plasma serotonin concentrations in glomerulonephritis II. Clin Nephrol 13: 112-123
31. Piazza V, De Filiipi C, Aprile C, Efficace E, Pisati P, Sacchi S, Salvadeo A 1993 Uraemic pruritus and plasma histamine concentrations. Nephrol Dial Transplant 8: 670-674
32. Poignet J, Callebert J, Delons S, Tabuteau F, Chauveau P, Bonete R, Launay JM, Man NK 1989 Plasma histamine levels and kinetics in chronic hemodialysis patients. ASAIO Trans 35: 252-254
33. Ponticelli C, Bencini PL 1992 Uremic pruritus. Nephron 60: 1-5
34. Roila F, Ballatori E, Tonato M, Del Favero A 1997 5-HT3 receptor antagonists: differences and similarities. Eur J Cancer 33: 1364-1370
35. Schwörer H, Ramadori R 1993 Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Invest 71: 659-662
36. Sebeková K, Raucinová M, Dzúrik R 1989 Serotonin metabolism in patients with decreased renal function. Nephrol 53: 229-232
37. Ståhle-Bäckdahl M 1989 Uremic pruritus: clinical features and experimental studies. Acta Derm Venereol Suppl 145: 1-38
38. Stockenhuber F, Kurz RW, Sertl K, Grimm G, Balcke P 1990 Increased plasma histamine levels in uraemic pruritus. Clin Sci 79: 477-482
39. Szepietowski J, Thepen T, van Vloten WA, Szepietowski T, Bihari IC 1995 Pruritus and mast cell proliferation in the skin of haemodialysis patients. Inflamm Res 44 (Suppl 1): S84-85
40. Weisshaar E, Ziethen B, Gollnick H 1997 Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res 46: 412-416
41. Weisshaar E, Ziethen B, Gollnick H 1999 The antipruritic effect of a 5-HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion - an experimental study. Exp Dermatol 8: 254-260
42. Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M 2001 A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 81: 108-111